[1]
2022. Protection of intestinal immune barrier against ischemia/reperfusion injury in a swine model using anisodamine hydrobromide. Brazilian Journal of Pharmaceutical Sciences. 58, (Dec. 2022). DOI:https://doi.org/10.1590/s2175-97902022e20870.